Medication knowledge: An initial step in self-management for youth with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 6, 2011, Pages 641-645

  Fishman, Laurie N ^a   Houtman, Dirk ^c   Van Groningen, Julia ^c   Arnold, Janis ^a   Ziniel, Sonja ^b  

^a Center for Inflammatory Bowel Disease   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

adolescent; inflammatory bowel disease; knowledge; medication; side effect

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BALSALAZIDE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; ENTERITIS; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; IMMUNOMODULATION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION KNOWLEDGE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SELF MEDICATION;

ADOLESCENT; CHILD; CHRONIC DISEASE; DISEASE MANAGEMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; OUTPATIENTS; QUESTIONNAIRES; SELF CARE; YOUNG ADULT;

EID: 82355183535     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182285316     Document Type: Article

References (19)

1. Baldassano R, Ferry G, Griffiths A, et al. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenter-ology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002; 34:245-8. (Pubitemid 34437511)
2. Hait E, Arnold JH, Fishman LN. Educate, communicate, anticipate-practical recommendations for transitioning adolescents with IBD to adult health care. Inflamm Bowel Dis 2006;12:70-3. (Pubitemid 43032455)
3. Patton SR, Graham JL, Holsclaw D Jr et al. Survey of professionals' expectations of developmental task achievement of cystic fibrosis self-care in children. Pediatr Pulmonol 2005;40:135-40. (Pubitemid 41099429)
4. Hait EJ, Barendse Re M, Arnold JH, et al. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr 2009;48: 61-5.
5. Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications? N Z Med J 2002;115: U183.
6. Vilke GM, Marino A, Iskander J, et al. Emergency department patient knowledge of medications. J Emerg Med 2000;19:327-30.
7. Makaryus AN, Friedman EA. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc 2005;80:991-994. (Pubitemid 41099383)
8. Ayana M, Pound P, Lampe F, et al. Improving stroke patients' care: a patient held record is not enough. BMC Health Serv Res 2001;1:1.
9. Ko H, Turner T, Jones C, et al. Patient-held medical records for patients with chronic disease: a systematic review. Qual Saf Health Care 2010;19:e41.
10. Cullen G, Donnellan F, Long S, et al. Perceptions of medication safety among patients with inflammatory bowel disease. Scand J Gastroenterol 2010;45:1076-83.
11. Fishman LN, Barendse RM, Hait E, et al. Self-management of older adolescents with inflammatory bowel disease: a pilot study of behavior and knowledge as prelude to transition. Clin Pediatr 2010; 49:1129-33.
12. Calkins DR, Davis RB, Reiley P, et al. Patient-physician communication at hospital discharge and patients' understanding of the postdischarge treatment plan. Arch Intern Med 1997;157:1026-30. (Pubitemid 27190893)
13. Paling J. Strategies to help patients understand risks. BMJ 2003; 327:745-8. (Pubitemid 37176764)
14. Carling CL, Kristoffersen DT, Oxman AD, et al. The effect of how outcomes are framed on decisions about whether to take antihyperten-sive medication: a randomized trial. PLoS One 2010;5:e9469.
15. Carling CL, Kristoffersen DT, Flottorp S, et al. The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial. PLoS Med 2009;6:e1000140.
16. Siegel CA, Levy LC, Mackenzie TA, et al. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1-6. (Pubitemid 351196861)
17. Day AS, Whitten KE, Bohane TD. Childhood inflammatory bowel disease: parental concerns and expectations. World J Gastroenterol 2005;11:1028-31. (Pubitemid 40347757)
18. Waters EA, Weinstein ND, Colditz GA, et al. Explanations for side effect aversion in preventive medical treatment decisions. Health Psychol 2009;28:201-9.
19. Traylor AH, Subramanian U, Uratsu CS, et al. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 2010;33:520-5.